Cytochroma's Series B - II Round

Cytochroma raised a round of funding on December 18, 2001.

Cytochroma is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products to treat and prevent the clinical consequences of vitamin D insufficiency and SHPT as…

Articles about Cytochroma's Series B - II Round: